Post by
SouthernTierTom on Oct 27, 2020 7:09am
Paradigm needs to RE-INTERATE their $4 CAD SP target "STAT"!
Spectral, Estor, Dialco, Baxter and ....wait for it ....Fresenius. Those paying close enough attention are aware of our relationship with Fresenius as well. We've done business with them in at least 8 EU nations. I will also point out that Fresenius ended their "relationship" with CTSO in Europe about two or three years ago.
I'm excited about Claudio's Big show and even more excited to hear about how PMX is helping in the fight against #19 ( Not Josh ), the virus...although he too was a "form of" said virus...just an intentional one ; - )
Take the time to cut and paste the link posted earlier on the 38th Vicenza conference. I challenge anybody to find any firm, of any size, that has more content at Vicenza than EDTXF. Pennies per presentation if you will. We've all been sold on the "suitability" of the Paradigm 60 cent CAD deal, let's move on show the world just how SAMI, DIMI, PMX, the EAA and our countless data points are helping the planet in the biggest medical hour of need since 1917. Oh and hey Corey, make your $4 SP target reall again, they really only have 3 month shelf lives, we need an update and a re-interate....if there was only ( DIMI FDA APPROVAL ) something significant to write about ; - )
Bon chance,
Tom